Steroid Drugs: Research

(asked on 17th January 2022) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether there is a specialist team within (a) his Department and (b) NHS England assessing topical steroid withdrawal reactions.


Answered by
Maria Caulfield Portrait
Maria Caulfield
Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
This question was answered on 15th February 2022

The Medicines and Healthcare products Regulatory Agency (MHRA) reviewed topical steroid withdrawal and in September 2021 issued advice to inform prescribers and patients of the risks of long term treatment, which is available at the following link:

https://www.gov.uk/drug-safety-update/topical-corticosteroids-information-on-the-risk-of-topical-steroid-withdrawal-reactions

Following the review, patient information leaflets are being amended to add warnings regarding long term use and the development of topical steroid withdrawal. The MHRA has also developed a safety leaflet, which is available at the following link:

https://www.gov.uk/guidance/topical-corticosteroids-and-withdrawal-reactions

While there is no specialist team in the Department or NHS England, the MHRA has published an assessment of topical steroid withdrawal reactions, which is available at the following link:

https://www.gov.uk/government/publications/topical-steroid-withdrawal-reactions-a-review-of-the-evidence

The MHRA continues to monitor reports received via the Yellow Card Scheme. No specific work has been undertaken with Scratch That.

Reticulating Splines